Literature DB >> 18687813

Physicians' and nurses' views on infected health care workers.

Ilya Kagan1, Karin Lee Ovadia, Tami Kaneti.   

Abstract

This study investigated 204 doctors' and nurses' perceived knowledge of bloodborne pathogens and their attitudes towards bloodborne pathogen-infected health care workers. A structured questionnaire examined: (1) their perceived knowledge of bloodborne pathogens; (2) their attitudes towards bloodborne pathogen-infected personnel; and (3) their opinions on limitation of employment of bloodborne pathogen-infected personnel and restrictions on performing clinical procedures. The levels of HIV-related knowledge were significantly higher than for hepatitis C and B viruses. Although the participants demonstrated more positive attitudes towards hepatitis C- and B-infected health care workers, 64% recommended restricting infected personnel from performing invasive procedures. Attitudes were negatively correlated with opinions on restricting infected personnel from health care work or limiting their involvement in clinical activities. This study highlights the need to formulate a policy to cope with the professional and moral dilemmas related to infected health care workers employed in hospitals, especially for those involved in invasive procedures.

Entities:  

Mesh:

Year:  2008        PMID: 18687813     DOI: 10.1177/0969733007088362

Source DB:  PubMed          Journal:  Nurs Ethics        ISSN: 0969-7330            Impact factor:   2.874


  2 in total

1.  How do healthcare professionals respond to ethical challenges regarding information management? A review of empirical studies.

Authors:  Cornelius Ewuoso; Susan Hall; Kris Dierickx
Journal:  Glob Bioeth       Date:  2021-04-05

2.  Psychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis.

Authors:  Shahin Ghasemi; Ali Kabir; Mojtaba Ansari Jafari; Mohammad Jalali; Afshin Amini; Amir Hossein Faghihi-Kashani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2012-12-31       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.